Stokes Frank's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 18, 2026
- Accession no.
- 0001628280-26-057644
- Filed
- Aug 18, 2026, 4:10 PM ET
- Trade date
- Aug 14, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $741.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stokes FrankCIK 0001782815 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | SSaleDisposed | −24,908 | $29.77 | −$741,511.16 | 35,177 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.